- Report
- May 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- March 2025
- 181 Pages
Asia Pacific
From €2594EUR$2,850USD£2,224GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- May 2023
- 89 Pages
Global
From €3500EUR$4,120USD£3,106GBP
The Leukemia Test market is a segment of the Diagnostics industry that focuses on the detection and diagnosis of leukemia, a type of cancer of the blood and bone marrow. Tests used to diagnose leukemia include blood tests, bone marrow tests, and imaging tests. Blood tests measure the number of white blood cells, red blood cells, and platelets in the blood. Bone marrow tests involve taking a sample of bone marrow and examining it under a microscope. Imaging tests, such as X-rays, CT scans, and MRIs, can help detect the presence of leukemia in the body.
The Leukemia Test market is highly competitive, with a range of companies offering products and services. Some of the major players in the market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, and Quest Diagnostics. Show Less Read more